TY  - JOUR
AU  - Sanchez-Ceinos, Julia
AU  - Rangel-Zuniga, Oriol A.
AU  - Clemente-Postigo, Mercedes
AU  - Podadera-Herreros, Alicia
AU  - Camargo, Antonio
AU  - Francisco Alcala-Diaz, Juan
AU  - Guzman-Ruiz, Rocio
AU  - Lopez-Miranda, Jose
AU  - Malagon, Maria M.
PY  - 2021
DO  - 10.1016/j.omtn.2021.01.014
SN  - 2162-2531
UR  - http://hdl.handle.net/10668/18859
T2  - Molecular therapy-nucleic acids
AB  - Circulating microRNAs (miRNAs) have been proposed as biomarkers for type 2 diabetes (T2D). Adipose tissue (AT), for which dysfunction is widely associated with T2D development, has been reported as a major source of circulating miRNAs. However, the...
LA  - en
PB  - Cell press
KW  - Insulin-resistance
KW  - Circulating mirnas
KW  - Oxidative stress
KW  - Glucose-uptake
KW  - Obesity
KW  - Adipocytes
KW  - Expression
KW  - Micrornas
KW  - Intervention
KW  - Activation
KW  - MicroRNAs
KW  - Circulating microRNA
KW  - Olive oil
KW  - Glucose
KW  - Adipocytes
KW  - Inflammation
KW  - Cardiovascular diseases
KW  - Tumor necrosis factors
TI  - miR-223-3p as a potential biomarker and player for adipose tissue dysfunction preceding type 2 diabetes onset
TY  - research article
VL  - 23
ER  -